Wells Fargo & Company MN Has $12,677,000 Position in Bruker Corp. (BRKR)
Wells Fargo & Company MN increased its stake in Bruker Corp. (NASDAQ:BRKR) by 36.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 559,670 shares of the company’s stock after buying an additional 149,523 shares during the period. Wells Fargo & Company MN’s holdings in Bruker Corp. were worth $12,677,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Societe Generale bought a new position in shares of Bruker Corp. during the second quarter valued at $135,000. Pacer Advisors Inc. bought a new position in shares of Bruker Corp. during the second quarter valued at $189,000. Legal & General Group Plc raised its position in shares of Bruker Corp. by 4.1% in the second quarter. Legal & General Group Plc now owns 8,460 shares of the company’s stock valued at $192,000 after buying an additional 335 shares during the last quarter. Bank of Hawaii raised its position in shares of Bruker Corp. by 23.6% in the second quarter. Bank of Hawaii now owns 9,150 shares of the company’s stock valued at $208,000 after buying an additional 1,750 shares during the last quarter. Finally, New York State Teachers Retirement System bought a new position in shares of Bruker Corp. during the second quarter valued at $218,000. Institutional investors and hedge funds own 67.74% of the company’s stock.
Bruker Corp. (NASDAQ:BRKR) traded up 2.210% during mid-day trading on Tuesday, hitting $23.355. 334,164 shares of the stock were exchanged. The company has a market cap of $3.74 billion, a P/E ratio of 26.390 and a beta of 1.04. The company has a 50-day moving average price of $21.80 and a 200-day moving average price of $23.16. Bruker Corp. has a one year low of $19.59 and a one year high of $29.85.
Bruker Corp. (NASDAQ:BRKR) last released its earnings results on Wednesday, November 2nd. The company reported $0.32 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.20 by $0.12. Bruker Corp. had a return on equity of 26.05% and a net margin of 9.02%. The company had revenue of $393.90 million for the quarter, compared to analysts’ expectations of $394.14 million. During the same quarter in the previous year, the business posted $0.19 EPS. The business’s revenue for the quarter was down .6% on a year-over-year basis. On average, analysts predict that Bruker Corp. will post $1.10 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 23rd. Shareholders of record on Monday, December 5th will be paid a dividend of $0.04 per share. The ex-dividend date of this dividend is Thursday, December 1st. This represents a $0.16 annualized dividend and a yield of 0.70%. Bruker Corp.’s dividend payout ratio (DPR) is presently 18.18%.
ILLEGAL ACTIVITY WARNING: This piece was originally reported by Daily Political and is owned by of Daily Political. If you are reading this piece on another domain, it was copied illegally and republished in violation of international trademark and copyright laws. The legal version of this piece can be viewed at http://www.dailypolitical.com/2016/11/29/wells-fargo-company-mn-has-12677000-position-in-bruker-corp-brkr.html.
BRKR has been the topic of several recent analyst reports. Cantor Fitzgerald cut their price objective on shares of Bruker Corp. from $34.00 to $28.00 and set a “buy” rating on the stock in a report on Wednesday, August 3rd. Janney Montgomery Scott upgraded shares of Bruker Corp. from a “neutral” rating to a “buy” rating and set a $28.00 price objective on the stock in a report on Wednesday, August 3rd. Zacks Investment Research upgraded shares of Bruker Corp. from a “hold” rating to a “buy” rating and set a $25.00 price objective on the stock in a report on Monday, November 7th. Morgan Stanley set a $23.00 price objective on shares of Bruker Corp. and gave the stock a “hold” rating in a report on Wednesday, August 3rd. Finally, Leerink Swann initiated coverage on shares of Bruker Corp. in a report on Thursday, November 10th. They set a “market perform” rating and a $21.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $25.73.
In other Bruker Corp. news, CEO Frank H. Laukien bought 2,124 shares of the stock in a transaction on Friday, November 25th. The shares were bought at an average price of $22.90 per share, with a total value of $48,639.60. Following the purchase, the chief executive officer now directly owns 37,699,606 shares in the company, valued at approximately $863,320,977.40. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 35.80% of the company’s stock.
Bruker Corp. Company Profile
Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.
Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Corp. (NASDAQ:BRKR).
Receive News & Ratings for Bruker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corp. and related companies with MarketBeat.com's FREE daily email newsletter.